Core Insights - Apimeds Pharmaceuticals US, Inc. announced the expansion of the Apimeds ai² Futures Lab program through a collaboration with the University of Oregon's Lundquist College of Business [1] - The initiative aims to connect student teams with real-world biopharma business development projects [1] - This expansion reinforces Apimeds' commitment to fostering innovation, leadership, and discovery in the health sector [1] Company Developments - The collaboration with the University of Oregon will begin in the Winter 2026 quarter [1] - The program is designed to enhance the practical experience of students while contributing to the biopharma industry [1] Industry Impact - The initiative reflects a growing trend in the biopharma industry to engage with educational institutions for talent development and innovation [1] - By connecting academia with industry projects, the program aims to drive advancements in biopharma business development [1]